PURE Bioscience (OTCMKTS:PURE – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.07 and traded as high as $0.09. PURE Bioscience shares last traded at $0.06, with a volume of 37,556 shares changing hands.
PURE Bioscience Trading Up 33.3%
The firm has a fifty day simple moving average of $0.07 and a two-hundred day simple moving average of $0.07. The stock has a market cap of $10.40 million, a PE ratio of -2.67 and a beta of 0.21.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings results on Monday, June 15th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.51 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
See Also
- Five stocks we like better than PURE Bioscience
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
- Looking Beyond NVIDIA? These 3 AI ETFs Are Beating the Market
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
